ArticleJournal of education and health promotion2024
Comparative study of epilepsy registry system in America, England, Australia, and Iran.
Article in Journal of education and health promotion, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDisease registries are one of the important steps in the development of health information systems. The aim of this study was to compare epilepsy registration systems in the United States, England, and Australia and propose a National Epilepsy Registry System for Iran. MATERIALS AND
methodsThis study was a descriptive-comparative study conducted between 2020 and 2023, which involved the following steps: identification and selected countries with advanced registry systems in the world and Identification of their characteristics and comparison with each other. The research population included the epilepsy registration registry in Australia, England, the United States, and Iran. In this study, data were collected from forms, observations, and documents.
resultsIn Australia, all databases, reports, and minimum datasets are electronically sent to the Australian Epilepsy Register. In England, the Epilepsy Society is responsible for collecting information. In the United States, all individuals with epilepsy voluntarily send their information to registry centers and the Epilepsy Society to help with their treatment. However, there is no national epilepsy registry system in Iran. Therefore, recommendations have been made to establish.
conclusionRegistration systems can help collect and analyze data related to all patients with a particular disease. When this registration is established at the national level, it becomes a valuable clinical tool for improving the quality of care and can be a significant step toward managing care for epilepsy patients and healthcare centers. Indeed, such a system can also help in preventing the onset of epilepsy and planning for the improvement of the quality of life for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.